CN102215824B - 具有延迟释放的固体药物制剂 - Google Patents
具有延迟释放的固体药物制剂 Download PDFInfo
- Publication number
- CN102215824B CN102215824B CN200980116218.0A CN200980116218A CN102215824B CN 102215824 B CN102215824 B CN 102215824B CN 200980116218 A CN200980116218 A CN 200980116218A CN 102215824 B CN102215824 B CN 102215824B
- Authority
- CN
- China
- Prior art keywords
- alkyl
- spp
- solid pharmaceutical
- polyvinylpyrrolidone
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(C(OC(*)C(N(C(*)C(OC(*)C(N(C)C(*)C(OC1*)=O)=O)=O)N)=O)=O)N(C)C1=O Chemical compound CC(C(OC(*)C(N(C(*)C(OC(*)C(N(C)C(*)C(OC1*)=O)=O)=O)N)=O)=O)N(C)C1=O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
R1 | R2 | R3 | R4 | R5 | R6 |
-CHMeCH2Me | -环己基 | -CHMeCH2Me | -Me | -CHMeCH2Me | -Me |
-CHMeCH2Me | -环己基 | -CHMeCH2Me | -Me | -CHMeCH2Me | -环己基 |
-CHMeCH2Me | -CH2-Phe | -CHMeCH2Me | -Me | -CHMeCH2Me | -Me |
-CHMeCH2Me | -CH2-Phe | -CHMeCH2Me | -Me | -CHMeCH2Me | -CH2-Phe |
-CHMeCH2Me | -(CH2)3-Me | -CHMeCH2Me | -Me | -CHMeCH2Me | -Me |
-CHMeCH2Me | -(CH2)3-Me | -CHMeCH2Me | -Me | -CHMeCH2Me | -(CH2)3-Me |
-CHMe2 | -CH2-Phe | -CHMeCH2Me | -Me | -CHMeCH2Me | -Me |
-CH2-Phe | -CHMe2 | -CH2-Phe | -CHMe2 | -CHMeCH2Me | -CHMe2 |
-CH2CHMe2 | -CH2-Phe | -CH2CHMe2 | -Me | -CH2CHMe2 | -CH2-Phe |
-(CH2)3-Me | -Me | -CHMeCH2Me | -Me | -CHMeCH2Me | -Me |
-CHMe2 | -Me | -CHMe2 | -Me | -CHMe2 | -Me |
-CH2-Me | -Me | -CH2-Me | -Me | -CH2-Me | -Me |
-(CH2)2-Me | -Me | -(CH2)2-Me | -Me | -(CH2)2-Me | -Me |
-(CH2)3-Me | -Me | -(CH2)3-Me | -Me | -(CH2)3-Me | -Me |
-CH2-CH=CH2 | -Me | -CH2-CH=CH2 | -Me | -(CH2)-CH=CH2 | -Me |
-CHMeCH2Me | -Me | -CHMeCH2Me | -Me | -CHMeCH2Me | -CH2-Me |
-CHMeCH2Me | -Me | -CHMeCH2Me | -Me | -CHMeCH2Me | -(CH2)2-Me |
-CHMeCH2Me | -Me | -CHMeCH2Me | -Me | -CHMeCH2Me | -(CH2)3-Me |
-CHMeCH2Me | -Me | -CHMeCH2Me | -Me | -CH2Me | -Me |
-CHMeCH2Me | -Me | -CHMeCH2Me | -Me | -(CH2)2-Me | -Me |
-环己基 | -Me | -环己基 | -Me | -环己基 | -Me |
-CH2CHMe2 | -环己基 | -CH2CHMe2 | -Me | -CH2CHMe2 | -环己基 |
-CH2CHMe2 | -环己基 | -CH2CHMe2 | -Me | -CH2CHMe2 | -Me |
-CHMeCH2Me | -CHMe2 | -CHMeCH2Me | -CHMe2 | -CHMeCH2Me | -Me |
-CH2-Phe | -Me | -CH2-Phe | -Me | -CH2-Phe | -Me |
-环己基 | -Me | -环己基 | -Me | -环己基 | -Me |
-CHMe2 | -CHMe2 | -CHMe | -Me | -CHMe2 | -Me |
-CHMe2 | -CHMe2 | -CHMe2 | -CHMe2 | -CHMe2 | -Me |
-CH2-Me | -CHMe2 | -CH2Me | -Me | -CH2-Me | -Me |
-CH2-Me | -CHMe2 | -CHMe2 | -CHMe2 | -CH2-Me | -Me |
-(CH2)2-Me | -CHMe2 | -(CH2)2-Me | -Me | -(CH2)2-Me | -Me |
-(CH2)2-Me | -CHMe2 | -(CH2)2-Me | -CHMe2 | -(CH2)2-Me | -Me |
-(CH2)3-Me | -CHMe2 | -(CH2)3-Me | -Me | -(CH2)3-Me | -Me |
-(CH2)3-Me | -CHMe2 | -(CH2)3-Me | -CHMe2 | -(CH2)3-Me | -Me |
-CH2-CH=CH2 | -CHMe2 | -CH2-CH=CH2 | -Me | -CH2-CH=CH2 | -Me |
-CH2-CH=CH2 | -CHMe2 | -CH2-CH=CH2 | -CHMe2 | -CH2-CH=CH2 | -Me |
-Me | -Me | -CHMeCH2Me | -Me | -CH2-Me | -Me |
-Me | -Me | -CHMeCH2Me | -Me | -(CH2)3-Me | -Me |
Claims (14)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008022520A DE102008022520A1 (de) | 2008-05-07 | 2008-05-07 | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
DE102008022520.7 | 2008-05-07 | ||
PCT/EP2009/002951 WO2009135593A2 (de) | 2008-05-07 | 2009-04-23 | Feste arzneimittelformulierung mit verzögerter freisetzung |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102215824A CN102215824A (zh) | 2011-10-12 |
CN102215824B true CN102215824B (zh) | 2015-06-03 |
Family
ID=40846135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980116218.0A Active CN102215824B (zh) | 2008-05-07 | 2009-04-23 | 具有延迟释放的固体药物制剂 |
Country Status (30)
Country | Link |
---|---|
US (2) | US20110046072A1 (zh) |
EP (1) | EP2285359B1 (zh) |
JP (1) | JP5539966B2 (zh) |
KR (1) | KR101663501B1 (zh) |
CN (1) | CN102215824B (zh) |
AR (1) | AR071620A1 (zh) |
AU (1) | AU2009243759B2 (zh) |
BR (1) | BRPI0912428A2 (zh) |
CA (1) | CA2723553C (zh) |
CL (1) | CL2009001016A1 (zh) |
CO (1) | CO6311067A2 (zh) |
DE (1) | DE102008022520A1 (zh) |
DK (1) | DK2285359T3 (zh) |
DO (1) | DOP2010000331A (zh) |
EC (1) | ECSP10010588A (zh) |
ES (1) | ES2393169T3 (zh) |
HK (1) | HK1162936A1 (zh) |
IL (1) | IL208486A0 (zh) |
MX (1) | MX2010012025A (zh) |
MY (1) | MY159492A (zh) |
NI (1) | NI201000189A (zh) |
NZ (1) | NZ589017A (zh) |
PE (1) | PE20091949A1 (zh) |
PL (1) | PL2285359T3 (zh) |
PT (1) | PT2285359E (zh) |
RU (1) | RU2548733C9 (zh) |
TW (1) | TWI441644B (zh) |
UA (1) | UA103025C2 (zh) |
UY (1) | UY31788A (zh) |
WO (1) | WO2009135593A2 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102258769B1 (ko) * | 2011-10-14 | 2021-06-01 | 지엘팜텍주식회사 | 장용소화효소제 및 그 제조방법 |
KR101979049B1 (ko) * | 2011-12-21 | 2019-05-15 | 바이엘 파마 악티엔게젤샤프트 | 무정형 에모뎁시드를 함유하는 제제 |
KR101400791B1 (ko) * | 2012-10-04 | 2014-05-29 | 주식회사대성미생물연구소 | 동물용 복합 기능성 항생제 조성물 |
NZ708741A (en) * | 2012-12-19 | 2019-11-29 | Bayer Animal Health Gmbh | Tablets with improved acceptance and good storage stability |
WO2016141065A1 (en) * | 2015-03-03 | 2016-09-09 | Kindred Biosciences, Inc. | Compositions and methods for treatment and prevention of pyrexia in horses |
RU2717545C2 (ru) * | 2015-04-02 | 2020-03-24 | Мериал, Инк. | Комбинации противоглистных агентов и способы их применения |
AR104714A1 (es) | 2015-05-20 | 2017-08-09 | Merial Inc | Compuestos depsipeptídicos como antihelmínticos |
KR102427124B1 (ko) | 2015-12-28 | 2022-07-28 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 구충성 뎁시펩티드 화합물 |
JP6359234B2 (ja) * | 2016-06-09 | 2018-07-18 | Dsファーマアニマルヘルス株式会社 | 動物用徐放性製剤組成物 |
CA3044038A1 (en) | 2016-11-16 | 2018-05-24 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic depsipeptide compounds |
CN108888598A (zh) * | 2018-08-01 | 2018-11-27 | 江西成必信生物科技有限公司 | 口服易吸收的布他磷及其制备方法 |
JP7268340B2 (ja) | 2018-12-06 | 2023-05-08 | コニカミノルタ株式会社 | 3dプリンター成形用樹脂組成物及びそれを用いた成形体とその製造方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1972687A (zh) * | 2003-11-04 | 2007-05-30 | 拜耳医药保健股份公司 | 具有改进的药物性质的含有调味剂的药物制剂 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2362539C2 (de) | 1973-12-17 | 1986-05-07 | Merck Patent Gmbh, 6100 Darmstadt | 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
EP0134984B1 (en) | 1983-07-16 | 1988-07-13 | Beecham Group Plc | Benzazepine and benzoxazepine derivatives |
NO176766C (no) * | 1989-02-07 | 1995-05-24 | Meiji Seika Kaisha | Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
NL9000238A (nl) * | 1990-01-31 | 1991-08-16 | Aesculaap Bv | Veterinair fenytoinepreparaat. |
DE4139963A1 (de) * | 1991-12-04 | 1993-06-09 | Basf Ag, 6700 Ludwigshafen, De | Redispergierbares dispersionspulver aus n-vinylpyrrolidon-vinylacetat-copolymerisat, dessen herstellung und verwendung |
EP0634408B1 (en) | 1992-03-17 | 2002-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Depsipeptide derivative, production thereof and use thereof |
SE501389C2 (sv) * | 1992-04-24 | 1995-01-30 | Leiras Oy | Farmaceutiskt preparat och förfarande för dess framställning |
DE4317458A1 (de) | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
AU666563B2 (en) * | 1992-08-07 | 1996-02-15 | Wisconsin Alumni Research Foundation | Preparation of 19-nor-vitamin D compounds |
PL175026B1 (pl) * | 1992-09-18 | 1998-10-30 | Yamanouchi Pharma Co Ltd | Preparat typu hydrożelu o przedłużonym działaniu |
CN1073560C (zh) | 1993-02-19 | 2001-10-24 | 明治制果株式会社 | 环缩酚酸肽pf1022衍生物 |
DE4317432A1 (de) * | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
DE4317457A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
EP0718293B1 (en) | 1993-09-06 | 2002-03-13 | Fujisawa Pharmaceutical Co., Ltd. | Cyclodepsipeptide compound |
DE4401389A1 (de) | 1994-01-19 | 1995-07-20 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung |
DE4406025A1 (de) | 1994-02-24 | 1995-08-31 | Bayer Ag | Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung |
US5747446A (en) * | 1994-03-22 | 1998-05-05 | Beth Israel Deaconess Medical Center | Modified polypeptides with increased biological activity |
ES2163504T5 (es) * | 1994-05-06 | 2008-05-16 | Pfizer Inc. | Formas de dosificacion de liberacion controlada de azitromicina. |
DE4437198A1 (de) * | 1994-10-18 | 1996-04-25 | Bayer Ag | Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden |
DE69637876D1 (de) | 1995-06-30 | 2009-04-30 | Astellas Pharma Inc | Ng und zwischenprodukt dafür |
DE19531684A1 (de) * | 1995-08-29 | 1997-03-06 | Bayer Ag | Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung |
CN1082051C (zh) * | 1995-09-22 | 2002-04-03 | 明治制果株式会社 | 新的环缩肽pf1022物质的衍生物 |
DE19545639A1 (de) * | 1995-12-07 | 1997-06-12 | Bayer Ag | Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen |
AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
IT1303693B1 (it) * | 1998-11-03 | 2001-02-23 | Formenti Farmaceutici Spa | Composizioni a rilascio controllato di metamizolo. |
DE19920415A1 (de) * | 1999-05-04 | 2000-11-09 | Hexal Ag | Metamizol enthaltende, kontrolliert freisetzende pharmazeutische Zusammensetzung |
UY26615A1 (es) * | 2000-03-16 | 2001-10-25 | Pfizer Prod Inc | Inhibidor de la glucogeno fosforilasa. |
DE10031044A1 (de) * | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere |
JP4426286B2 (ja) * | 2001-07-10 | 2010-03-03 | テバ ファーマシューティカル インダストリーズ リミティド | 0次、0次−二相性、上昇型又は下降型薬物放出のための薬物送達システム |
US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
DE10212864B4 (de) * | 2002-03-22 | 2005-12-22 | Beiersdorf Ag | Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung |
US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
RS20050741A (en) * | 2003-04-02 | 2007-06-04 | Boehringer Ingelheim International Gmbh., | Pharmaceutical compositions for hepatitis c viral protease inhibitors |
TR200300510A2 (tr) * | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
US20050053658A1 (en) * | 2003-09-09 | 2005-03-10 | Venkatesh Gopi M. | Extended release systems for macrolide antibiotics |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
BRPI0417043A (pt) * | 2003-12-01 | 2007-02-06 | Lifecycle Pharma As | composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição |
DE10358525A1 (de) * | 2003-12-13 | 2005-07-07 | Bayer Healthcare Ag | Endoparasitizide Mittel zur topischen Applikation |
DE102004055316A1 (de) * | 2004-11-16 | 2006-05-18 | Bayer Healthcare Ag | Verhinderung vertikaler Endoparasiten-Infektionen |
AR055106A1 (es) * | 2005-08-05 | 2007-08-08 | Osmotica Pharmaceutical Argent | Composicion farmaceutica solida de liberacion extendida que contiene carbidopa y levodopa |
US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
AU2007247480B8 (en) * | 2006-04-28 | 2013-04-11 | Grunenthal Gmbh | Pharmaceutical combination comprising 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and an NSAID |
WO2008013197A1 (en) * | 2006-07-26 | 2008-01-31 | Asahi Kasei Chemicals Corporation | Spherical crude granule and method for production thereof |
DE102006044694A1 (de) * | 2006-09-22 | 2008-03-27 | Krewel Meuselbach Gmbh | Perorale feste Schmerzmittelzubereitung |
DE102007012644A1 (de) * | 2007-03-16 | 2008-09-18 | Bayer Healthcare Ag | Stabilisierung von Vitamin B12 |
-
2008
- 2008-05-07 DE DE102008022520A patent/DE102008022520A1/de not_active Withdrawn
-
2009
- 2009-04-23 CA CA2723553A patent/CA2723553C/en active Active
- 2009-04-23 JP JP2011507811A patent/JP5539966B2/ja active Active
- 2009-04-23 KR KR1020107027245A patent/KR101663501B1/ko active IP Right Grant
- 2009-04-23 PL PL09741812T patent/PL2285359T3/pl unknown
- 2009-04-23 EP EP09741812A patent/EP2285359B1/de active Active
- 2009-04-23 MX MX2010012025A patent/MX2010012025A/es active IP Right Grant
- 2009-04-23 MY MYPI2010005142A patent/MY159492A/en unknown
- 2009-04-23 US US12/990,389 patent/US20110046072A1/en not_active Abandoned
- 2009-04-23 AU AU2009243759A patent/AU2009243759B2/en active Active
- 2009-04-23 WO PCT/EP2009/002951 patent/WO2009135593A2/de active Application Filing
- 2009-04-23 PT PT09741812T patent/PT2285359E/pt unknown
- 2009-04-23 ES ES09741812T patent/ES2393169T3/es active Active
- 2009-04-23 UA UAA201014638A patent/UA103025C2/ru unknown
- 2009-04-23 DK DK09741812.3T patent/DK2285359T3/da active
- 2009-04-23 BR BRPI0912428A patent/BRPI0912428A2/pt not_active IP Right Cessation
- 2009-04-23 NZ NZ589017A patent/NZ589017A/xx unknown
- 2009-04-23 CN CN200980116218.0A patent/CN102215824B/zh active Active
- 2009-04-23 RU RU2010149561/15A patent/RU2548733C9/ru active
- 2009-04-27 PE PE2009000568A patent/PE20091949A1/es not_active Application Discontinuation
- 2009-04-28 CL CL2009001016A patent/CL2009001016A1/es unknown
- 2009-04-28 UY UY0001031788A patent/UY31788A/es not_active Application Discontinuation
- 2009-05-04 AR ARP090101599A patent/AR071620A1/es not_active Application Discontinuation
- 2009-05-06 TW TW098114933A patent/TWI441644B/zh active
-
2010
- 2010-10-05 IL IL208486A patent/IL208486A0/en active IP Right Grant
- 2010-11-04 CO CO10137282A patent/CO6311067A2/es not_active Application Discontinuation
- 2010-11-04 EC EC2010010588A patent/ECSP10010588A/es unknown
- 2010-11-05 DO DO2010000331A patent/DOP2010000331A/es unknown
- 2010-11-05 NI NI201000189A patent/NI201000189A/es unknown
-
2012
- 2012-04-10 HK HK12103484.3A patent/HK1162936A1/zh unknown
-
2014
- 2014-04-18 US US14/256,921 patent/US20150150985A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1972687A (zh) * | 2003-11-04 | 2007-05-30 | 拜耳医药保健股份公司 | 具有改进的药物性质的含有调味剂的药物制剂 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102215824B (zh) | 具有延迟释放的固体药物制剂 | |
US7914816B2 (en) | Endoparasiticidal agents for voluntary oral ingestion by animals | |
BRPI0417578B1 (pt) | composições endoparasiticidas, seu uso e seu processo de preparação | |
AU2018202376B2 (en) | Preparations containing amorphous emodepside | |
JP4202422B2 (ja) | ヘキサヒドロピラジン誘導体の経口投与できる顆粒剤 | |
NZ625817B2 (en) | Preparations containing amorphous emodepside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1162936 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH Free format text: FORMER OWNER: BAYER ANIMAL HEALTH GMBH Effective date: 20130129 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130129 Address after: German Monheim Applicant after: Bayer Pharma Aktiengesellschaft Address before: Germany Leverkusen Applicant before: Bayer Animal Health GmbH |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1162936 Country of ref document: HK |